About this event

  • Date and time Wed 5 Feb 2020 from 8:45am to 5:00pm
  • Location Royal Society of Medicine
  • Organised by Gastroenterology and Hepatology

The RSM and Oxford Centre for Personalised Medicine (CPM) will bring together an exceptional group of national and international experts in their fields to review the most recent advances of both the science underlying the aetiology of colorectal cancer and the current and future clinical management.

This conference will provide a unique forum for consultants, specialist registrars and clinical nurse specialists in gastroenterology, oncology and colorectal surgery to discuss our current understanding and future approaches to the management of colorectal cancer.

There are 20 bursary places available for medical students on a first-come, first-served basis - please contact the Gastroenterology section to claim your place. 


Learning objectives:

  • Review our current understanding of predisposition, genetic risk and clonal evolution in the aetiology of colorectal cancer
  • Understand the role of molecular stratification and iteration in the assessment of colorectal cancer
  • Explore the latest endoscopic techniques used to both detect and treat colorectal cancer
  • Review the optimum current and future surgical management of colorectal cancer
  • Understand the latest therapeutic advances the oncological management of colorectal cancer
  • Understand the role of ex-vivo drug screening in future of colorectal cancer treatment

Join in the conversation online

Follow us on Twitter: @RoySocMed

We would like to thank our exhibitors:

Amgen, Merck and Servier Laboratories Limited

Please note that none of the companies listed have had any influence or involvement over the agenda, content or organisation of this meeting.

Key speakers

Professor Ian Tomlinson

Director of the Institute of Cancer and Genomic Sciences, University of Birmingham

Dr Janet Graham

Honorary Clinical Senior Lecturer, University of Glasgow

Professor Viktor Koelzer

Attending Pathologist, Institute of Pathology and Molecular Pathology, University of Zurich

Professor Brian Saunders

Professor in Endoscopy, St Marks Hospital London


View the programme

Registration, tea and coffee
Welcome and introduction

Session one: Predisposition/clonal evolution

Predisposition and Population Genetic Risk in Colorectal Cancer

Professor Ian Tomlinson, Director of the Institute of Cancer and Genomic Sciences, University of Birmingham 

Clonal evolution in colorectal cancer

Professor Trevor Graham, Professor of Cancer Evolution, Queen Mary University of London

Tea and coffee break

Session two: Molecular stratification

Professor Marco Novelli, University College Hospital 

Molecular stratification of colorectal cancer 

Professor Tim Maughan, Professor of Clinical Oncology, University of Oxford 

Morphological and molecular iteration in colorectal cancer

Professor Viktor Koelzer, Attending Pathologist, Institute of Pathology and Molecular Pathology, University of Zurich 


Session three: Detection

 Advances in lesion detection and therapeutic colonoscopy

Professor Brian Saunders, Professor in Endoscopy, St Marks Hospital London

Session four: Therapy

Colorectal cancer: Prevention better than therapy

Dr Farhat Din, Clinician Scientist for Cancer Research UK, University of Edinburgh 

Tea and coffee break
Next generation biopsies in colorectal cancer: From liquid biopsies to ex vivo personalised drug screenings

Dr Nicola Valeri, Reader in Personalised Oncology and Gastrointestinal Cancer Biology and Genomics Team Leader, Institute of Cancer Research

Advances in Medical oncology in colorectal cancer

Dr Janet Graham, Honorary Clinical Senior Lecturer, University of Glasgow 

Close of meeting



Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom